Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Alteogen is holding a domestic Non-Deal Roadshow (NDR) in Seoul from April 8 to April 10, 2025, for domestic and foreign institutional investors to present the status of licensed technology deals and long-term growth strategies.
📊 [Key Disclosure Details & Financial Highlights]
- Date & Time: 2025-04-08 ~ 2025-04-10 (09:00 ~ 17:00 Local Time)
- Location: Seoul area
- Target Audience: Major domestic and foreign institutional investors
- Purpose: Explanation of company status (progress on licensed agreement items, etc.) and long-term growth strategy
- Event Format: Domestic NDR (Non-Deal Roadshow)
- Key Agenda: Corporate presentation, FAQ, Q&A
- Host/Sponsor: Shinhan Securities
- Scheduled IR Material Upload Date & Location: 2025-04-07 / Korea Exchange KIND system (http://kind.krx.co.kr)
- Department in Charge: IR Group (+82-42-384-8777)
- Confirmation Date: 2025-03-26
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 IR Presentation Filing and Progress Updates on Licensed Technologies
This Investor Relations event provides an opportunity to share the latest progress on licensed technology items and pipeline developments directly with institutional investors. Checking the IR presentation slides published a day prior to the event is important to verify the exact status of key licensing deals and any updates to the company’s growth strategy. The official presentation materials can be accessed on or after April 7, 2025, via the ‘IR Material Filing’ section on the Korea Exchange KIND system or the IR section of Alteogen’s official website.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
